nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0505	0.0518	CbGpPWpGaD
Labetalol—ADRB3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0431	0.0442	CbGpPWpGaD
Labetalol—ADRB3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0418	0.0429	CbGpPWpGaD
Labetalol—ADRB3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0389	0.04	CbGpPWpGaD
Labetalol—ADRB3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0362	0.0371	CbGpPWpGaD
Labetalol—ADRB3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0351	0.0361	CbGpPWpGaD
Labetalol—ADRB3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0327	0.0336	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.03	0.0308	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0293	0.0301	CbGpPWpGaD
Labetalol—ADRB3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0273	0.028	CbGpPWpGaD
Labetalol—Lisdexamfetamine—SLC6A3—Gilles de la Tourette syndrome	0.0257	1	CrCbGaD
Labetalol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0256	0.0262	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.025	0.0257	CbGpPWpGaD
Labetalol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0248	0.0255	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0243	0.0249	CbGpPWpGaD
Labetalol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0231	0.0237	CbGpPWpGaD
Labetalol—ADRB3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0229	0.0235	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0226	0.0232	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0215	0.022	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.021	0.0216	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0209	0.0214	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0204	0.0209	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0194	0.0199	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.019	0.0195	CbGpPWpGaD
Labetalol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0162	0.0166	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0158	0.0163	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0136	0.014	CbGpPWpGaD
Labetalol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.0135	0.0138	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0133	0.0137	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0111	0.0114	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0108	0.0111	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00831	0.00853	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00807	0.00828	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00751	0.00771	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00712	0.00731	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00703	0.00722	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00691	0.00709	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00644	0.00661	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00542	0.00556	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00526	0.0054	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00526	0.0054	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00493	0.00506	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0049	0.00503	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00482	0.00495	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00479	0.00491	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00468	0.00481	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00451	0.00463	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00446	0.00458	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00436	0.00448	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00423	0.00434	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00413	0.00424	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0041	0.00421	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00401	0.00412	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00382	0.00392	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00374	0.00384	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00343	0.00352	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00322	0.0033	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00315	0.00323	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00312	0.00321	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00312	0.00321	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00306	0.00314	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00306	0.00314	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00306	0.00314	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00297	0.00305	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00291	0.00299	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00285	0.00292	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00278	0.00286	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00277	0.00284	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0027	0.00277	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00268	0.00275	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00262	0.00269	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00252	0.00258	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00204	0.00209	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00199	0.00205	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00194	0.00199	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00182	0.00187	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00178	0.00183	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00177	0.00181	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00176	0.00181	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00173	0.00177	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00165	0.00169	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00164	0.00169	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00164	0.00169	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00162	0.00166	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00161	0.00165	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0016	0.00165	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0016	0.00164	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00157	0.00161	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00151	0.00155	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00149	0.00153	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00149	0.00153	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00146	0.0015	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00118	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00113	0.00116	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00107	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00104	0.00107	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00105	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000975	0.001	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000954	0.000979	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000947	0.000972	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000926	0.000951	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000882	0.000905	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000863	0.000886	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000618	0.000634	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000604	0.00062	CbGpPWpGaD
